No Prescription |
 |
 | ||
|
Cresar Micardis |
|
| ||
No Prescription » Prescription Drugs 5 » Cresar Micardis Telmisartan is used alone or in combination with other medications to treat high blood pressure. Telmisartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain chemicals that tighten the blood vessels so blood flows more smoothly. Telmisartan comes as a tablet to take by mouth. It is usually taken once a day with or without food. To help you remember to take telmisartan take it around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take telmisartan exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Your doctor may start you on a low dose of telmisartan and gradually increase your dose. Telmisartan controls high blood pressure but does not cure it. Continue to take telmisartan even if you feel well. Do not stop taking telmisartan without talking to your doctor. High blood pressure reduction helps prevent strokes heart attacks and kidney problems. This drug works by blocking the hormone angiotensin thereby relaxing blood vessels causing them to widen. Telmisartan belongs to a class of drugs called angiotensin receptor blockers. OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional. This drug may also be used to treat congestive heart failure and to help protect the kidneys from damage due to diabetes. How to use Temisartan OralTake this medication by mouth usually once daily or as directed by your doctor. You may take this drug with or without food. Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time each day. Do not take potassium supplements or salt substitutes containing potassium without talking to your doctor or pharmacist first. This medicine can raise your potassium levels which rarely can cause serious side effects such as muscle weakness or very slow heartbeats. Tell your doctor immediately if these effects occur. The dosage is based on your medical condition and response to therapy. For the treatment of high blood pressure it may take 4 weeks before the full benefit of this drug occurs. Buy Cresar Micardis and other Prescription Drugs 5 products online at Medstore. Buy Online at Medstore - Click Here!
About Cresar Micardis: Product Type: Prescription Drugs 5 Cresar ( Micardis Generic Telmisartan ) Cresar (Micardis Generic Telmisartan) Micardis Generic Telmisartan 20mg 100 Tablets 20mg 200 (2 x 100 Tabs) 20mg 400 (4 x 100 Tabs) 40mg 200 (2 x 100 Tabs) 40mg 100 Tablets 40mg 400 (4 x 100 Tabs) 80mg 400 Tablets 80mg 100 Tablets 80mg 200 Tablets Micardis Generic Telmisartan Cresar
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
